{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:26:29Z","timestamp":1780673189582,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["17-33127A"],"award-info":[{"award-number":["17-33127A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00296-019-04301-z","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T15:06:23Z","timestamp":1556204783000},"page":"1037-1043","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-6996","authenticated-orcid":false,"given":"Hana","family":"Hulejov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-4329","authenticated-orcid":false,"given":"Tereza","family":"Krop\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-1022","authenticated-orcid":false,"given":"Krist\u00fdna","family":"Bubov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-6246","authenticated-orcid":false,"given":"Olga","family":"Kry\u0161t\u016ffkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8488-9227","authenticated-orcid":false,"given":"M\u00e1ria","family":"Filkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-235X","authenticated-orcid":false,"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-7895","authenticated-orcid":false,"given":"\u0160\u00e1rka","family":"Forejtov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8616-7850","authenticated-orcid":false,"given":"Michal","family":"Tom\u010d\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-0713","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-8422","authenticated-orcid":false,"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-7312","authenticated-orcid":false,"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"issue":"10089","key":"4301_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384","journal-title":"Lancet"},{"issue":"1","key":"4301_CR2","doi-asserted-by":"publisher","first-page":"e000319","DOI":"10.1136\/rmdopen-2016-000319","volume":"3","author":"MC Turina","year":"2017","unstructured":"Turina MC, Yeremenko N, van Gaalen F et al (2017) Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort. RMD Open 3(1):e000319","journal-title":"RMD Open"},{"issue":"12","key":"4301_CR3","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1136\/annrheumdis-2013-203824","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy D, Conrad K, Haibel H et al (2014) Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis. Ann Rheum Dis 73(12):2137\u20132143","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4301_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.autrev.2016.02.002","volume":"15","author":"K Prajzlerova","year":"2016","unstructured":"Prajzlerova K, Grobelna K, Pavelka K, Senolt L, Filkova M (2016) An update on biomarkers in axial spondyloarthritis. Autoimmun Rev 15(6):501\u2013509","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4301_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89\u201395","journal-title":"Clin Pharmacol Ther"},{"key":"4301_CR6","doi-asserted-by":"crossref","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11(2):85\u201397. \n                    http:\/\/www.nature.com\/articles\/nri2921\n                    \n                  . Accessed 21 Jan 2011","DOI":"10.1038\/nri2921"},{"key":"4301_CR7","doi-asserted-by":"crossref","unstructured":"Neumann E, Junker S, Schett G, Frommer K, Muller-Ladner U (2016) Adipokines in bone disease. Nat Rev Rheumatol 12(5):296\u2013302. <Go to ISI>:\/\/WOS:000375276700006","DOI":"10.1038\/nrrheum.2016.49"},{"issue":"3","key":"4301_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.38968","volume":"67","author":"U Syrbe","year":"2015","unstructured":"Syrbe U, Callhoff J, Conrad K et al (2015) Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. Arthritis Rheumatol 67(3):678\u2013685","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4301_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-017-1350-9","volume":"19","author":"A Hartl","year":"2017","unstructured":"Hartl A, Sieper J, Syrbe U et al (2017) Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial. Arthritis Res Ther 19(1):140. \n                    https:\/\/doi.org\/10.1186\/s13075-017-1350-9\n                    \n                  \n                           (Published online first 2017\/06\/18)","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4301_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","volume":"14","author":"B Samal","year":"1994","unstructured":"Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14(2):1431\u20131437","journal-title":"Mol Cell Biol"},{"issue":"3","key":"4301_CR11","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","volume":"178","author":"AR Moschen","year":"2007","unstructured":"Moschen AR, Kaser A, Enrich B et al (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178(3):1748\u20131758","journal-title":"J Immunol"},{"issue":"4","key":"4301_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1189\/jlb.0807581","volume":"83","author":"T Luk","year":"2008","unstructured":"Luk T, Malam Z, Marshall JC (2008) Pre-B cell colony-enhancing factor (PBEF)\/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83(4):804\u2013816","journal-title":"J Leukoc Biol"},{"issue":"3","key":"4301_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00223-006-0155-7","volume":"80","author":"H Xie","year":"2007","unstructured":"Xie H, Tang SY, Luo XH et al (2007) Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 80(3):201\u2013210","journal-title":"Calcif Tissue Int"},{"issue":"1\u20132","key":"4301_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mrfmmm.2009.06.012","volume":"690","author":"AR Moschen","year":"2010","unstructured":"Moschen AR, Geiger S, Gerner R, Tilg H (2010) Pre-B cell colony enhancing factor\/NAMPT\/visfatin and its role in inflammation-related bone disease. Mutat Res 690(1\u20132):95\u2013101","journal-title":"Mutat Res"},{"issue":"2","key":"4301_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3892\/mmr.2016.6069","volume":"15","author":"JM Baek","year":"2017","unstructured":"Baek JM, Ahn SJ, Cheon YH, Lee MS, Oh J, Kim JY (2017) Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-kappaB ligand-induced osteoclast differentiation in vitro. Mol Med Rep 15(2):784\u2013792","journal-title":"Mol Med Rep"},{"key":"4301_CR16","doi-asserted-by":"publisher","unstructured":"Hulejova H, Levitova A, Kuklova M et al (2012) No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis. Clin Rheumatol 31(1):67\u201371. \n                    https:\/\/doi.org\/10.1007\/s10067-011-1773-7\n                    \n                  . <Go to ISI>:\/\/WOS:000299768200009","DOI":"10.1007\/s10067-011-1773-7"},{"issue":"4","key":"4301_CR17","first-page":"538","volume":"31","author":"JA Miranda-Filloy","year":"2013","unstructured":"Miranda-Filloy JA, Lopez-Mejias R, Genre F et al (2013) Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy. Clin Exp Rheumatol 31(4):538\u2013545","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"4301_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783","journal-title":"Ann Rheum Dis"},{"key":"4301_CR19","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic-criteria for ankylosing-spondylitis\u2014a proposal for modification of the New-York criteria. Arthritis Rheum 27(4):361\u2013368. <Go to ISI>:\/\/WOS:A1984SN19400001"},{"issue":"9","key":"4301_CR20","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/art.22833","volume":"56","author":"F Brentano","year":"2007","unstructured":"Brentano F, Schorr O, Ospelt C et al (2007) Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56(9):2829\u20132839","journal-title":"Arthritis Rheum"},{"key":"4301_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000053","author":"X Baraliakos","year":"2015","unstructured":"Baraliakos X, Braun J (2015) Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2015-000053","journal-title":"RMD Open"},{"key":"4301_CR22","doi-asserted-by":"publisher","first-page":"7574147","DOI":"10.1155\/2017\/7574147","volume":"2017","author":"J Huang","year":"2017","unstructured":"Huang J, Yin Z, Song G et al (2017) Discriminating value of calprotectin in disease activity and progression of nonradiographic axial spondyloarthritis and ankylosing spondylitis. Dis Markers 2017:7574147. \n                    https:\/\/doi.org\/10.1155\/2017\/7574147\n                    \n                  \n                           (Published online first 2017\/06\/21)","journal-title":"Dis Markers"},{"issue":"1","key":"4301_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/eci.12369","volume":"45","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos X (2014) The contribution of imaging in the diagnosis and treatment of axial spondyloarthritis. Eur J Clin Investig 45(1):81\u201386. \n                    https:\/\/doi.org\/10.1111\/eci.12369\n                    \n                  \n                           (Published online first 2014\/11\/08)","journal-title":"Eur J Clin Investig"},{"issue":"Suppl 2","key":"4301_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/annrheumdis-2018-eular.7158","volume":"77","author":"X Baraliakos","year":"2018","unstructured":"Baraliakos X, Boehm H, Samir Barakat A et al (2018) OP0242 Fatty lesions detected on MRI scans in patients with ankylosing spondylitis are based on the deposition of fat in the vertebral bone marrow. Ann Rheum Dis 77(Suppl 2):170. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2018-eular.7158","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4301_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.diabres.2010.11.003","volume":"91","author":"A Esteghamati","year":"2011","unstructured":"Esteghamati A, Alamdari A, Zandieh A et al (2011) Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity. Diabetes Res Clin Pract 91(2):154\u2013158. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2010.11.003\n                    \n                  \n                           (Epub 2010 Nov 30)","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04301-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04301-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04301-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:14:05Z","timestamp":1587683645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04301-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04301-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standard of the local ethics committee of the Institute of Rheumatology in Prague, Czech Republic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Hana Hulejov\u00e1 declares that she does not have competing interests. Tereza Krop\u00e1\u010dkov\u00e1 declares that she does not have competing interests. Krist\u00fdna Bubov\u00e1 declares that she does not have competing interests. Olga Kry\u0161t\u016ffkov\u00e1 declares that she does not have competing interests. M\u00e1ria Filkov\u00e1 declares that she does not have competing interests. \u0160\u00e1rka Forejtov\u00e1 declares that she does not have competing interests. He\u0159man Mann declares that he does not have competing interests. Michal Tom\u010d\u00edk declares that he does not have competing interests. Ji\u0159\u00ed Vencovsk\u00fd declares that he does not have competing interests. Karel Pavelka declares that he does not have competing interests. Ladislav \u0160enolt declares that he does not have competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}